Skip to content

Neural Changes in the Aging Auditory System

Age-Related Hearing Loss: Presbycusis & Its Neural Bases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00264407
Enrollment
126
Registered
2005-12-12
Start date
2001-01-31
Completion date
2005-02-28
Last updated
2005-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory Perceptual Disorders, Estrogens, Hearing, Progesterone, Psychoacoustics

Keywords

Hearing Loss, Central, Presbycusis, Hearing Loss, Sensorineural, Hearing Loss, Cochlear, Hearing Loss, Bilateral, Sex Steroid Hormones, Estradiol

Brief summary

The purpose of this study was to determine the effects of hormone replacement therapy (HRT) on hearing in post-menopausal women.

Detailed description

Background: Female hormone influences on the development and aging of the auditory system are not completely understood. The present study retrospectively analyzed and compared hearing abilities among post-menopausal women taking hormone replacement therapy (HRT), treated with estrogen and progesterone (E+P); estrogen alone (E), and a third (control - NHRT) group, matched for age, who did not receive any HRT. Methods: 126 subjects, (60-86 yr), N=32, E+P; N=31, E; N= 63, NHRT; matched for age and health status participated. All had relatively healthy medical histories, absence of significant noise exposure, middle ear problems, major surgeries or current/heavy smoking. Hearing tests included pure tone audiometry (PTA), tympanometry, distortion-product otoacoustic emissions (DPOAEs), transient otoacoustic emissions (TEOAEs) and hearing-in-noise-test (HINT). The latter is a test for speech perception in background noise: the major complaint of hearing-impaired persons. .

Interventions

DRUGHormone Replacement Therapy - HRT

Sponsors

Rochester Institute of Technology
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
University of Rochester
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
60 Years to 86 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy middle ears

Exclusion criteria

* ototoxic medications * serious medical health problems * neurological conditions * Meniere's disease or labyrinthitis * those who failed cognitive screening tests (Mini-Mental Test) * current/heavy smokers * conductive hearing loss * history of noise damage and/or audiograms signifying noise damage * poor speech discrimination scores (80% or less)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026